Tech Company Financing Transactions
Swift Biosciences Funding Round
Swift Biosciences, operating out of Ann Arbor, scored $3 million in funding from Mercury Fund and private investors.
Transaction Overview
Company Name
Announced On
8/12/2010
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Investors
Mercury Fund (Lead Investor) (Daniel Watkins)
Proceeds Purpose
This funding will help us accelerate product development and customer testing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
674 S. Wagner Rd. 100
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Overview
Swift Biosciences is developing molecular biology reagents for research and diagnostic applications.Our products help users to detect genes and gene products that other products can't. We also help users to analyze their samples faster, at higher volume, and at a lower price-per-sample.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nathan Wood
Chief Financial Officer
James Militello
Chief Scientific Officer
Vladimir Makarov
VP - Marketing
Camille Cappello
VP - Product Management
Laurie Kurihara
VP - Sales
Haley Fiske
Browse more venture capital transactions:
Prev: 8/12/2010: Pure Storage venture capital transaction
Next: 8/12/2010: iScience Interventional venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs